SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-20-000053
Filing Date
2020-10-13
Accepted
2020-10-13 09:05:48
Documents
16
Period of Report
2020-10-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-20201013.htm   iXBRL 8-K 38023
7 IMAGE image11.jpg GRAPHIC 23191
8 EX-99 gallopgpppressrelease1.htm EX-99 25103
  Complete submission text file 0001370053-20-000053.txt   259316

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20201013.xsd EX-101.SCH 2442
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20201013_cal.xml EX-101.CAL 726
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20201013_def.xml EX-101.DEF 2904
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20201013_lab.xml EX-101.LAB 27354
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20201013_pre.xml EX-101.PRE 14829
9 EXTRACTED XBRL INSTANCE DOCUMENT anab-20201013_htm.xml XML 11293
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 201234863
SIC: 2834 Pharmaceutical Preparations